Rick Simpson Oil (RSO) in Fremont County, Colorado: The Complete Guide by OilWell Cannabis

Understanding RSO: From Nova Scotia to Fremont County

If you’re reading this from Fremont County, Colorado — whether you’re in Cañon City, Florence, or the unincorporated stretches of our beautiful mountain valleys — you’ve likely heard the term “RSO” floating through conversations about cannabis, chronic pain, cancer support, or sleep issues. Maybe a neighbor mentioned it at the grocery store. Maybe you saw it in an online forum while researching alternatives to opioids. Maybe your oncologist at St. Thomas More Hospital or one of the clinics along Highway 50 quietly suggested looking into cannabinoid therapy as a complement to conventional treatment.

Rick Simpson Oil isn’t just another cannabis product. It’s a movement that started with one man’s desperation after the medical system failed him — a story that resonates deeply here in Fremont County, where many of us have watched loved ones cycle through ineffective prescriptions or struggle to access specialized care. The original RSO was crude, unstandardized, and made with petroleum-based solvents in a rice cooker. It was never lab-tested. It never came with a Certificate of Analysis. Yet it sparked a global conversation about cannabis as medicine that eventually reached our corner of Colorado.

We at OilWell Cannabis respect Rick Simpson’s legacy. We also believe that people in Fremont County deserve something better: a formula that honors the RSO tradition while meeting modern safety, precision, and legal standards. That’s what we’ve built — not just for Houston, where we’re based, but for every community that needs honest access to cannabinoid medicine, including yours.

The Rick Simpson Story: Why It Matters to Fremont County

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia. He wasn’t a doctor, scientist, or researcher. He was a power engineer — a blue-collar tradesman who understood machinery, not medicine. In 1997, while working at a hospital in Moncton, he fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. His doctors prescribed medications that either didn’t help or made things worse. When he asked his physician about cannabis, the request was refused.

Sound familiar? In Fremont County, where access to specialized neurology or pain management often requires a two-hour drive to Colorado Springs or Pueblo, many residents face the same pattern: workplace injuries, chronic post-injury symptoms, and a medical system that sometimes dismisses cannabis as an option.

Simpson’s pivotal moment came in 2003. Three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursue surgery or radiation, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed they disappeared within four days. No independent medical verification was ever published. No biopsy confirmation exists in any peer-reviewed source. But this personal testimony became the origin story of RSO and the catalyst for a global movement.

Important context: Simpson’s account is personal testimony, not medical evidence. It is historically significant because it inspired millions to explore cannabis oil — including people in Fremont County who are searching for alternatives right now. But personal stories are not clinical proof. We honor his story by being honest about that distinction.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson developed a specific dosing regimen that spread worldwide through his documentary Run From The Cure (2005). It was designed for a crude, variable, untested product — and it’s still what many people find when they search online for “RSO dosing.” Fremont County residents deserve to know exactly what that protocol entails, even if they ultimately choose a safer, modern approach.

The 60-Gram Goal: Consume approximately 60 grams of concentrated cannabis oil over roughly 90 days. Simpson considered this the minimum for a serious cancer treatment course.

Titration Schedule:

• Week 1: Half a grain of rice-sized dose (10–15 mg) three times daily. Total daily intake: 30–45 mg.
• Weeks 2–5: Double the dose every four days until reaching 1 gram (1,000 mg) per day, divided into three doses.
• Weeks 5–12: Maintain 1 gram per day until all 60 grams are consumed.

Administration Methods:

• Oral/sublingual: Primary route for systemic absorption.
• Topical: For skin lesions, applied directly and covered with bandages.
• Inhalation: Not recommended as primary treatment, but acknowledged for immediate symptom relief.

Important context for evaluating this protocol:

• No controlled trial has ever validated it.
• Traditional RSO potency was unknown and varied wildly (estimated 60–90% THC).
• Peak dosing delivered 600–900 mg of delta-9 THC per day — far exceeding doses studied in clinical settings.
• Real risks at these doses include severe intoxication, anxiety, tachycardia, hypotension, and cannabis use disorder.
• For oncology patients in Fremont County using unregulated oil as primary treatment instead of proven therapies, the harm potential is serious.

What Simpson got right: He drew attention to cannabinoids as a biomedical research area when the world was ignoring it. He helped create the conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: The leap from preclinical signals to cancer cure was not supported then and is not supported now. Delaying or foregoing proven oncologic therapies for unverified cannabis oil carries genuine harm potential. We cannot emphasize this enough for Fremont County readers navigating cancer treatment decisions.

About OilWell Cannabis: From a Paralyzed Dog to Science-Based Formulas

Bentley’s Story: The Foundation of Everything

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — across the river from Reynosa, Mexico, in one of the most economically challenged and dangerous border regions. By sixteen, after witnessing violence and losing friends to the streets, he’d left home for good. He learned to hustle, but he never fell into selling harder substances. He focused on cannabis, seeing it as a safer path.

Later, Colin became a formally trained software engineer and did custom development work for Baylor College of Medicine. That combination — deep plant knowledge plus medical-grade technical precision — defines OilWell’s approach.

But the company’s origin story isn’t about software or Houston. It’s about a dog named Bentley.

Bentley was paralyzed in his back legs. Vets at the Texas A&M veterinary school recommended euthanasia, warning that pain medications would destroy his organs. Colin refused to give up. A rescue worker named Jessica asked him: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

That question changed everything.

Colin created a CBD golden paste for Bentley:

• ½ cup organic turmeric powder
• 1 cup water
• ⅓ cup coconut oil
• 1–2 tsp freshly ground black pepper
• CBD oil (dose adjusted for pet size)

Bentley got up. He walked. He brought Colin his ball to play. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During that decade, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → CBG for neuroprotection, THCa for PPARγ agonism
• Dementia → CBC for neurogenesis
• Glaucoma → THC for CB1 agonism and intraocular pressure
• Arthritis → Multi-pathway anti-inflammatory approach using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids were not enough. Bentley’s needs required multi-cannabinoid synergy. That necessity became OilWell’s philosophy.

Colin’s Personal Journey: PTSD, Benzo Withdrawal, and Peace Gummies

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and Xanax addiction. When he quit cold turkey — a notoriously dangerous feat — he used the same cannabinoid knowledge that kept Bentley alive. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. He personally uses the vape form for insomnia and severe PTSD to this day.

This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not. That lived experience makes OilWell credible in a way no corporate brand can replicate.

Media Recognition: Seven ABC13 Features, Five Reporters, Four Years

Between September 2019 and April 2023, ABC13 Houston featured Colin and OilWell in seven distinct segments. No other Houston cannabis operator matches that frequency or breadth. The features spanned:

1. CBD business boom (Sept 2019) — Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

2. Decriminalization and ecosystem building (Mar 2021) — Colin helped other entrepreneurs, emphasizing that “pain comes in a lot of different forms.”

3. Delta-8 THC investigation (May 2021) — Colin’s iconic exchange: Steve Campion: “Why would someone want to smoke that?” Colin: “Maybe you want to get high.”

4. COVID vaccine giveaway (Aug 2021) — OilWell donated 1,000 caviar pre-rolls (~$35,000 in product) to encourage vaccination, coordinating with the city of Houston. No political strings attached.

5. Delta-8 ban impact (Oct 2021) — Texas DSHS classified Delta-8 as Schedule I overnight. Colin proactively removed all products before enforcement and warned other operators who were unknowingly shipping narcotics.

6. Biden marijuana pardon (Oct 2022) — Colin revealed his personal marijuana conviction history. “I would love to see people not get hurt for this anymore.”

7. 4/20 industry creative evolution (Apr 2023) — Colin grew hemp on camera, framing the present as a “Renaissance” moment for Texas cannabis.

Five different reporters sought Colin out. That kind of sustained media recognition cannot be purchased. It is earned through consistency, community action, and personal stakes.

The OilWell RSO Philosophy: Evolution, Not Repetition

OilWell’s RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in deliberate, evidence-motivated ways.

Four Core Principles

1. Accessibility over gatekeeping. No medical card required. Age 21+ only. Ships nationwide and internationally. Simpson believed medicine should be accessible; we built a product and distribution model that makes that legally possible for Fremont County residents.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for daytime anti-inflammatory benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry.

3. Open-source formulas. We publish our complete formulas publicly. If you cannot afford our products, you can source the ingredients and make your own version. Simpson gave his oil away for free; we adapted that ethos for the modern marketplace by selling a professionally manufactured product and publishing the recipe.

4. Evidence-informed, not evidence-overstating. The GENERAL KNOWLEDGE section that follows represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

Farm Bill Compliance and the THCa Legal Framework

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our product design.

Our RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle — 3 mg per mL — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in Colorado.

THCa is the key. It is the acidic, non-psychoactive precursor to delta-9 THC. It is not delta-9 THC at the point of sale, making it Farm Bill compliant.

Practical significance for Fremont County residents:

• Raw use: All 1,500 mg THCa stays non-psychoactive. Compatible with work, driving, and daytime use with zero impairment.
• Home activation: Heat the oil at 260°F (125°C) for 45–60 minutes. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC — psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.
• Vape auto-decarb: The RSO Vape Cartridge vaporizes at 400–450°F, instantly converting THCa to delta-9 THC with each puff.

Conversion chemistry: THCa molecular weight is 358.47 g/mol. The conversion ratio is 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation.

Important legal notice: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with local laws. We ship with full documentation, COAs, and receipts. International customers accept all customs and legal risk.

For Fremont County residents, this framework means you can legally purchase, possess, and transport our product, then activate it in the privacy of your home. This is the most significant legal cannabis access innovation in history — backed by actual chemistry, not loopholes.

Open-Source Formulas: Why We Publish Everything

We publish our complete RSO formulas publicly. Every cannabinoid, every milligram, every percentage. If you cannot afford our products, you can source the ingredients and make your own version. This is a direct echo of Rick Simpson’s free-distribution ethos.

The Bentley Recipe: Our Original Open-Source Formula

We published the CBD golden paste that saved Bentley’s life years before we open-sourced the RSO formulas. Here it is again:

Ingredients:

• ½ cup organic turmeric powder
• 1 cup water
• ⅓ cup coconut oil (unrefined, organic)
• 1–2 tsp freshly ground black pepper
• CBD oil (dose depends on pet size; consult a veterinarian)

Instructions:

1. Mix turmeric and water in a saucepan over low heat, stirring continuously until a thick paste forms (7–10 minutes).
2. Add coconut oil and pepper. Stir until thoroughly mixed.
3. Cool and store in a jar with lid. Refrigerate up to 2 weeks.
4. Add CBD oil to paste before serving. Start with a low dose and increase as needed.

Serving: Mix a small amount with pet’s food once or twice daily. Monitor for changes and consult a veterinarian. Always consult a vet before starting any new supplement regimen.

This recipe demonstrates that open-source is foundational behavior, not marketing strategy. We gave away the formula that saved Bentley before we gave away the formula for people. The pattern is consistent.

The Decarboxylation Choice: Three Usage Options

Traditional RSO was always fully decarboxylated. You had no choice about psychoactivity. Our product gives you three distinct options:

Option 1 — Raw, no heat. All 1,500 mg stays as THCa. Non-psychoactive. Use for daytime anti-inflammatory support without impairment. The THCa evidence profile suggests COX-2 inhibition and neuroprotective PPARγ agonism [12].

Option 2 — Fully activated, home decarb. Heat at 260°F for 45–60 minutes. Converts THCa to ~1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC and 6,000 mg delta-8 THC, this delivers psychoactive potency comparable to traditional high-THC RSO. You can decarb the entire bottle or transfer a controlled portion to a second container, preserving the remainder raw.

Option 3 — Vape, auto-decarboxylation. The RSO Vape Cartridge vaporizes at 400–450°F, instantly converting THCa to delta-9 THC with each puff. Fastest onset (1–2 minutes).

This design puts the potency decision entirely in your hands — aligning with Simpson’s principle that patients should control their medicine, but implementing it through actual product chemistry.

Solvent-Free Production

Our RSO is not a traditional extraction product. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents are present in the finished product.

We use organic MCT oil as the carrier base. MCT oil facilitates sublingual absorption and provides a neutral taste profile — a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers:

• Cannabinoid potency (HPLC/UHPLC analysis, ±2% accuracy)
• Terpene profile
• Pesticides (400+ compound screening via LC-MS/MS and GC-MS/MS)
• Heavy metals (ICP-MS testing for arsenic, cadmium, lead, mercury)
• Residual solvents (headspace GC, FDA Class 3 limits <5,000 ppm)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis (COAs) are available on request and accessible through our website.

Two Product Formats: Sublingual Oil and Vape Cartridge

We offer the RSO formula in two delivery formats, each with distinct pharmacokinetic profiles.

RSO Sublingual Oil — $129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg/mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper for precise 0.1 mL dosing
• Onset: 15–45 minutes
• Peak: 1–2 hours
• Duration: 4–6 hours
• Bioavailability: 13–19%
• Approximately 40–60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900+ mg total cannabinoids
• Same six-cannabinoid ratio as sublingual (delta-9 THC not listed separately; THCa auto-decarbs at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1–2 minutes (fastest delivery)
• Peak: 10–15 minutes
• Duration: 2–4 hours
• Bioavailability: 10–35%
• Auto-decarboxylation at 400–450°F

When to Use Each Format

Condition-Specific Usage Context for Fremont County Residents

Important disclaimer: The following contexts are informed by cannabinoid research cited below and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-related nausea and appetite support:

• Pre-chemo: 0.5–1.0 mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2–3 vape puffs for immediate relief
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep during treatment: 1.0–2.0 mL sublingual before bed (delivers 25–50 mg CBN)
• Evidence: delta-8 antiemetic [9], delta-9 nausea evidence [1][13], CBD anxiolytic buffering [3]

Chronic pain (fibromyalgia, arthritis, neuropathy):

• Daytime: 0.3–0.5 mL raw sublingual — anti-inflammatory cannabinoid exposure without impairment
• Nighttime: 0.5–1.0 mL decarbed sublingual — pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed
• Evidence: CBD pain [4], delta-9 pain [13], caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep support:

• Before bed: 1.0–2.0 mL sublingual
• At 2.0 mL: delivers 50 mg CBN — dosage level investigated in 2024 sleep literature
• At 1.0 mL: delivers 25 mg CBN — above threshold associated with reduced sleep disturbance
• Evidence: CBN sleep [16][17], cannabis sleep review [17]

Anxiety and stress:

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

General titration principle: Start low, go slow. Begin with 0.25–0.5 mL sublingual and assess effects over 2–3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and Global Accessibility: Reaching Fremont County

We operate the only same-day RSO delivery system in Houston. For Fremont County residents, we offer nationwide shipping.

Nationwide Shipping to Colorado:

• All 50 states where Farm Bill-compliant products are legal
• USPS Priority Mail (2–3 business days), FedEx and UPS Ground (3–5 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for summer shipments
• Signature-required option available

International Shipping:
We ship internationally and have delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill.

• All international packages include full documentation, COAs, and receipts for customs
• Minimum flat-fee shipping applies; excessive costs billed to customer
• Customer is responsible for verifying legality in their jurisdiction and accepts all customs and legal risk
• Contact: (832) 416-2816 or [email protected]

For Fremont County residents: Whether you’re in Cañon City, Florence, or the rural communities along the Arkansas River, you can access the same clinical-strength RSO formula that Houston patients receive. No medical card. No dispensary visit required. Just legal, tested, multi-cannabinoid medicine delivered to your door.

Our PANDEM1C SEO technology — a proprietary system with 14 million geopolitical locations in its database and over 300 AI models — drives organic search visibility across six continents, making our products discoverable to patients searching for RSO in their own language.

Evidence Profiles: The Science Behind Every Milligram

Cannabinoids: What the Research Actually Says

CBD (4,500 mg in sublingual oil)

• Strongest evidence: Purified CBD for rare epilepsies — the clearest major-example indication acknowledged by institutional literature [1][2].
• Anxiety: 2024 systematic review/meta-analysis of 316 participants across eight studies reported significant anxiolytic signal, but authors stressed limited clinical sample and need for more trials [3].
• Pain: 2024 systematic review concluded promising but heterogeneous literature, with trial quality limiting confidence in broad analgesic claims [4].
• Sleep: 2023 insomnia review found methodologically weak literature, with few objective sleep assessments [5].
• Safety: 2023 systematic review/meta-analysis found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6]. NCCIH flags diarrhea, sleepiness, appetite changes, mood effects, liver abnormalities, and drug interactions [1].

Bottom line for Fremont County: CBD is the most evidence-developed non-intoxicating cannabinoid, but strong evidence is concentrated in specific indications rather than broad wellness claims.

CBG (3,000 mg)

• Evidence profile: Mostly review-level and preclinical; human evidence sparse [7][8].
• Pharmacology: Biosynthetic precursor to major cannabinoids. Interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling — mechanistically interesting but not clinically established [7].
• Research areas: Possible relevance to neurologic disorders, inflammatory bowel disease, antibacterial activity — primarily pharmacology-led hypotheses [7][8].
• Caution: Being sold commercially while evidence base remains thin; claims often outrun science [7].
• Bottom line: Promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC (6,000 mg)

• Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Comparative pharmacology: 2022 review concluded similar PK/PD behavior to delta-9 THC, but less potent due to weaker CB1 affinity [9].
• Public health: 2023 scoping review found evidence base dominated by animal studies, chemistry, use reports, and safety concerns rather than strong human trials [10].
• Manufacturing: Commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels; product-byproduct and lab-testing concerns are real [11].
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and manufacturing-quality uncertainty [9]-[11].

THCa (1,500 mg)

• Evidence profile: Important chemically, but low on direct human therapeutic evidence [12].
• What it is: Acidic precursor to THC; represents large share of THC-related content in raw plant material. Decarboxylates to THC during heating and can change over time [12].
• Psychoactivity: THCa itself does not produce psychoactive effects, but distinction only holds if molecule stays acidic and is not decarboxylated [12].
• Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities — not equivalent to established human outcomes [12].
• Bottom line: Highly relevant precursor whose interpretation depends heavily on route, temperature, processing, and storage [12].

Delta-9 THC (90 mg)

• Evidence profile: Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15].
• Institutionally supported: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS and pain outcomes — many other uses uncertain [1].
• Pain evidence: 2022 systematic review found high-THC or comparable THC:CBD products may provide short-term pain benefit but increase dizziness, sedation, nausea, and discontinuation due to adverse events [13].
• Pharmacokinetics: Inhaled THC: onset seconds to minutes, peak 15–30 minutes, duration few hours. Oral THC: later onset, later peak, longer duration [14].
• Mental health risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety and depression [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape lung injury [1][14][15].
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN (750 mg)

• Evidence profile: Weak human evidence; marketing moved ahead of data [12][16][17].
• Marketed for: Sleep and sedation. Clinical support far thinner than market suggests [16][17].
• Best review: 2021 narrative review screened 99 human-study abstracts, reviewed eight full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].
• Broader sleep literature: 2024 updated review concluded cannabinoid sleep research still doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: THC can degrade toward CBN under certain conditions, explaining why CBN is often discussed in aging/oxidized cannabis contexts [12].
• Bottom line: Cultural reputation stronger than current clinical evidence base [16][17].

CBC (750 mg)

• Evidence profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].
• Pharmacology: 2024 focused review argues distinct PK/PD and receptor behavior relative to better-known cannabinoids; highlights antinociceptive, antibacterial, anti-seizure as interesting research targets [18].
• Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance — not strong evidence for patient-facing claims [19].
• Safety caveat: Over-the-counter CBC products already sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpenes: What the Research Actually Says

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene (citrus-bright aroma)

• Evidence profile: Largely review and preclinical [20]-[22].
• Potential activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities — but overwhelming share from nonhuman/non-cannabis literature [21].
• Safety note: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens in patch-testing literature [22].
• Bottom line: Biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans [20]-[22].

Myrcene

• Evidence profile: Mostly preclinical, very limited human evidence [20][23].
• Research summary: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties and possible mechanisms, but explicitly states human studies lacking [23].
• Interpretation caution: Often invoked as proven sedative explaining couch-lock — stronger claim than human evidence currently supports [20][23].
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof [23].

Caryophyllene (pepper/spice aroma)

• Evidence profile: Among most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24].
• Why it stands out: 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist — unusual and especially relevant when discussing cannabis terpenes pharmacologically [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective — human clinical confirmation limited [24].
• Bottom line: Arguably strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven for outcomes commonly attributed to it [24].

Pinene (forest-fresh aroma)

• Evidence profile: Promising preclinical literature, weak human clinical confirmation [20][25].
• Brain-health framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized lack of well-designed clinical trials [25].
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].
• Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool (floral, lavender aroma)

• Evidence profile: Similar to pinene — substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research summary: Repeatedly discussed in relation to stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation, while emphasizing lack of robust human trials [25].
• Additional literature: Separate review discusses possible antidepressant mechanisms and neuropharmacologic relevance — still translational rather than definitive clinical story [26].
• Safety note: Oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22].
• Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene (earthy, woody aroma)

• Evidence profile: Translationally interesting, but still early [20][27].
• Scoping-review findings: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Interpretation caution: Findings valuable for hypothesis generation, but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].
• Bottom line: Among more interesting terpene research targets, but remains far from clinically settled [27].

Terpinolene (piney, fruity, sparkling aroma)

• Evidence profile: One of least clinically characterized terpenes in this file [20][28].
• Systematic-review findings: 2021 review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base still dominated by in silico, in vitro, and animal studies rather than human trials [28].
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].
• Bottom line: Biologically interesting, but especially underdeveloped clinically [20][28].

Research Limits and Interpretation

1. Evidence base is highly uneven. CBD and delta-9 THC can support most detailed human-facing statements; the rest require more caution [1]-[29].
2. Extract/molecule/synthetic/terpene data aren’t interchangeable. Common error: letting evidence from one category stand in for another.
3. Minor cannabinoids and terpenes are commercially interesting BECAUSE they’re underexplored, but that also means claims often become inflated.
4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics materially affect real-world interpretation [1][10][11][14].
5. THCa chemistry changes with storage/heating. For THCa in particular, actual exposure profile can change by converting acidic cannabinoids into neutral cannabinoids like THC [12].

Common Overstatements to Avoid

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More accurate: Specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

• Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

• Overstatement: Terpenes in general have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

• Overstatement: Delta-8 THC is safe because it is hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Our Formulas

• CBD and delta-9 THC are the most evidence-developed actives in these formulas.
• Delta-8 THC is not a trivial or purely mild ingredient; it is a psychoactive cannabinoid with less robust safety and efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing and should not be interpreted the same way in raw, gently handled, and heated formats.
• CBG, CBN, and CBC are scientifically credible but clinically immature compared with CBD and THC.
• The listed terpenes are likely highly relevant to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

RSO Sublingual Oil Formula

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle with graduated dropper (0.1mL increments)
• Active per mL: 553mg total cannabinoids
• Carrier: Organic MCT oil
• Onset: 15–45 minutes
• Duration: 4–6 hours
• Bioavailability: 13–19%

RSO Vape Cartridge Formula

• Live Terpenes: 5%+
• Format: 1-gram 510-thread cartridge
• Onset: 1–2 minutes
• Duration: 2–4 hours
• Bioavailability: 10–35%

Terpene Profile (Both Products)

• Limonene: Citrus-bright aroma; multifunctional monoterpene with antioxidant, anti-inflammatory properties (mostly preclinical) [21]; contact allergen when oxidized [22]
• Myrcene: Found in hops and mangoes; anxiolytic and analgesic signals in preclinical literature, but human proof limited [23]
• Caryophyllene: Pepper/spice aroma; selective CB2 receptor agonist — unusual and pharmacologically relevant [24]
• Pinene: Forest-fresh aroma; neuroprotective preclinical signals, but human trials lacking [25]
• Linalool: Floral/lavender aroma; stress and mood pharmacology interest, but clinical confirmation limited [26]; oxidized form is contact allergen [22]
• Humulene: Earthy/woody aroma; anti-inflammatory preclinical evidence, some rodent cannabimimetic signals [27]
• Terpinolene: Piney/fruity aroma; least clinically characterized of the profile; mostly in vitro/animal studies [28]

How to Access OilWell RSO in Fremont County

Ordering Process

1. Visit our website: OilWellCBD.com
2. Verify age: 21+ required
3. Select product: RSO Sublingual Oil ($129.99) or RSO Vape Cartridge ($49.99)
4. Shipping to Colorado: We ship to all Colorado addresses, including Fremont County. USPS Priority Mail (2–3 business days) or FedEx/UPS Ground (3–5 business days)
5. Discreet packaging: No cannabis branding visible
6. Tracking: Provided for all orders
7. Documentation: Full COAs, receipts, and Farm Bill compliance paperwork included

Legal Status in Colorado

Colorado has legal adult-use cannabis. However, many Fremont County residents prefer hemp-derived products because:

• No need to visit a dispensary (nearest may be in Pueblo or Colorado Springs)
• No medical card required
• Can be shipped directly to your home
• Contains less than 0.3% delta-9 THC at point of sale, making it federally legal

Our product meets all Colorado hemp product requirements. The THCa in our formula is Farm Bill compliant. The delta-9 THC content (90 mg total in a 30 mL bottle) is well below the 0.3% threshold. You are legally purchasing a hemp-derived product.

Your responsibility: If you choose to decarboxylate the THCa into delta-9 THC, you are responsible for understanding local possession limits. Under Colorado law, adults 21+ can possess up to 2 ounces of cannabis. The decarboxylated product from one bottle (~1,405 mg delta-9 THC) is well within personal use limits.

Payment and Support

• Payment: Major credit cards accepted
• Customer service: (832) 416-2816 or [email protected]
• Hours: Monday–Thursday 10 AM–7 PM, Friday–Saturday 10 AM–10 PM, Sunday 10 AM–4 PM (Central Time)

Our Commitment to Fremont County

We know that people in Fremont County value honesty, self-reliance, and community. Whether you’re a veteran at the Royal Gorge Manor, a cancer patient at St. Thomas More, a chronic pain sufferer in Howard, or a caregiver in Penrose — you deserve transparent information about what you’re putting in your body.

We promise:

• No snake oil. We publish our formulas. We cite our evidence. We tell you what’s proven, what’s promising, and what’s overstated.
• No gatekeeping. No medical card. No dispensary requirement. We ship to your door in Fremont County.
• Patient control. You decide whether your medicine is psychoactive or not. You decide your dose. You decide your path.
• Quality you can verify. Every batch is third-party tested. Every COA is available. Every claim is anchored to peer-reviewed literature.

Rick Simpson started a movement by giving his oil away for free and teaching people to make it themselves. We honor that by selling a professional product and publishing the recipe. If you can afford it, we’ll provide the best version we can make. If you can’t, we’ll give you the knowledge to make your own.

That’s the OilWell difference. That’s why we’re here for Fremont County.

Final Thoughts for Our Fremont County Community

We recognize that cannabis still carries stigma in some circles. We recognize that discussing RSO in a small community like Fremont County can feel risky. We’re not here to advocate for recklessness. We’re here to provide the best possible version of the information so you can give it a fair shot and decide whether it’s right or wrong for you.

The evidence is clear: no cannabis product has been proven to cure cancer in humans. But the evidence is also clear that cannabinoids have legitimate therapeutic potential for pain, nausea, sleep, anxiety, and inflammation when used responsibly and in conjunction with professional medical care.

If you’re a cancer patient at the Heart of the Rockies Regional Medical Center, we urge you to discuss any cannabinoid use with your oncologist. If you’re a veteran struggling with PTSD, we encourage you to coordinate with the VA clinic in Pueblo. If you’re a chronic pain patient, we hope you’ll consider cannabinoids as part of a comprehensive pain management plan rather than a standalone miracle.

Our formulas are designed to be tools in your toolbox — not the whole workshop. They’re designed to be safe enough for daily use, flexible enough for your lifestyle, and transparent enough that you never have to wonder what you’re actually taking.

From our home in Houston to your home in Fremont County, we’re honored to be part of your journey toward better health.

OilWell Cannabis — 810 Richmond Avenue, Houston, TX 77006 — (832) 416-2816 — OilWellCBD.com